Risk stratification for sudden cardiac death in hypertrophic cardiomyopathy: Dutch cardiologists and the care of mutation carriers

Netherlands Heart Journal

Volumn 17, Issue 12, 2009, Pages 464-469

  Vehmeijer, J T ^a   Christiaans, I ^a   van Langen, I M ^a   Birnie, E ^b   Bonsel, G J ^b   Smets, E M A ^a   Wilde, A A M ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Hypertrophic cardiomyopathy; Questionnaire; Risk stratifi cation; Sudden cardiac death

Indexed keywords

ADULT; ARTICLE; CARDIOLOGIST; CLINICAL EVALUATION; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; GENETIC ANALYSIS; GENETIC SCREENING; HEART TRANSPLANTATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; JOB EXPERIENCE; KNOWLEDGE; MAJOR CLINICAL STUDY; MALE; PATIENT CARE; PRACTICE GUIDELINE; PREVALENCE; PROPHYLAXIS; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; SUDDEN CARDIAC DEATH; TRAINING;

EID: 77949639018     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/BF03086305     Document Type: Article

References (17)

1. Maron BJ, Gardin JM, Flack JM, Gidding SS, Kurosaki TT, Bild DE. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults. Circulation. 1995;92:785-9.
2. Alcalai R, Seidman JG, Seidman CE. Genetic basis of hypertrop-hic cardiomyopathy: from bench to the clinics. J Cardiovasc Elec-trophysiol. 2008;19:104-10.
3. Elliott P, Andersson B, Arbustini E, et al. Classification of the car-diomyopathies: a position statement from the European Society Of Cardiology Working Group on Myocardial and Pericardial Disea-ses. Eur Heart J. 2008;29:270-6.
4. Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Car-diology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Trans-lational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-16.
5. Elliott P, McKenna WJ. Hypertrophic cardiomyopathy. Lancet. 2004;363:1881-91.
6. Elliott PM, Gimeno JR, Thaman R, et al. Historical trends in reported survival rates in patients with hypertrophic cardio-myopathy. Heart. 2006;92:785-91.
7. Maron BJ, Olivotto I, Spirito P, et al. Epidemiology of hyper-trophic cardiomyopathy-related death: revisited in a large non-referral-based patient population. Circulation. 2000;102:858-64.
8. Miller MA, Gomes JA, Fuster V. Risk stratification of sudden cardiac death in hypertrophic cardiomyopathy. Nat Clin Pract Cardiovasc Med. 2007;4:667-76.
9. Maron BJ, McKenna WJ, Danielson GK, et al. American College of Cardiology/European Society of Cardiology clinical expert consensus document on hypertrophic cardiomyopathy. A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines. J Am Coll Cardiol. 2003;42:1687-713.
10. Elliott PM, Poloniecki J, Dickie S, et al. Sudden death in hyper-trophic cardiomyopathy: identification of high risk patients. J Am Coll Cardiol. 2000;36:2212-8.
11. Epstein AE, Dimarco JP, Ellenbogen KA, et al. ACC/AHA/HRS 2008 Guidelines for Device-Based Therapy of Cardiac Rhythm Abnormalities: Executive Summary. A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the ACC/ AHA/NASPE 2002 Guideline Update for Implantation of Cardiac Pacemakers and Antiarrhythmia Devices). Circulation. 2008;117:e350-408.
12. Zipes DP, Camm AJ, Borggrefe M, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhyth-mias and the Prevention of Sudden Cardiac Death: a report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (writing committee to develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death): developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society. Circulation. 2006;114:e385-e484.
13. McKenna WJ, Spirito P, Desnos M, Dubourg O, Komajda M. Experience from clinical genetics in hypertrophic cardiomyopathy: proposal for new diagnostic criteria in adult members of affected families. Heart. 1997;77:130-2.
14. Niimura H, Bachinski LL, Sangwatanaroj S, et al. Mutations in the gene for cardiac myosin-binding protein C and late-onset familial hypertrophic cardiomyopathy. N Engl J Med. 1998;338:1248-57.
15. van Langen I, Birnie E, Leschot NJ, Bonsel GJ, Wilde AA. Genetic knowledge and counselling skills of Dutch cardiologists: sufficient for the genomics era? Eur Heart J. 2003;24:560-6.
16. Remme WJ, McMurray JJ, Hobbs FD, et al. Awareness and per-ception of heart failure among European cardiologists, internists, geriatricians, and primary care physicians. Eur Heart J. 2008;29: 1739-52.
17. Southwell C, Moallem M, Auckley D. Cardiologist’s knowledge and attitudes about obstructive sleep apnea: a survey study. Sleep Breath. 2008;12:295-302.